Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |